Eckert & Ziegler: Change in the Management of IBt Bebig

Eckert & Ziegler Strahlen- und Medizintechnik AG / Change of Personnel
24.03.2010 17:43

Dissemination of a Corporate News, transmitted by
DGAP - a company of EquityStory AG.
The issuer / publisher is solely responsible for the content of this announcement.

---

Berlin, March 24, 2010 - IBt Bebig, an affiliated company of Eckert & Ziegler (ISIN DE0005659700) announced today that the CEO, Mr François Blondel, and the Company have decided to end their collaboration.
As a result, Mr François Blondel will resign, with immediate effect, from all of his duties and responsibilities within the Group, whether as a Director of IBt s.a. or of its subsidiaries.

Dr. Edgar Löffler and Dr. Gunnar Mann, directors of IBt, have been appointed as the new persons in charge of the daily management of the company. They will take over the responsibilities of Mr. Blondel and manage IBt jointly, each in his capacity as Managing Director.

Eckert & Ziegler AG, Karolin Riehle, Investor Relations, Robert-Rössle-Str. 10, D-13125 Berlin
Tel.: +49 (0) 30 / 941084-138, Fax-112, E-Mail: karolin.riehle@ezag.de, www.ezag.com





24.03.2010 Ad hoc announcement, Financial News and Media Release distributed by DGAP. Media archive at www.dgap-medientreff.de and www.dgap.de

---

 
Language:     English
Company: Eckert & Ziegler Strahlen- und Medizintechnik AG               Robert-Rössle-Str.10
              13125 Berlin
              Deutschland
Phone:        49 30 941084-138
Fax:          49 30 941084-112
E-mail:       karolin.riehle@ezag.de
Internet:     www.ezag.de
ISIN:         DE0005659700, DE000A0L1L69
WKN:          565970, A0L1L6
Listed: Regulierter Markt in Frankfurt (Prime Standard), Stuttgart; Freiverkehr in Berlin, München, Düsseldorf, Hamburg  
End of News DGAP News-Service  

---